Austin, Texas, July 9, 2019 – Elligo Health Research, a healthcare-enabling research organization, announces its partnership with Austin Cancer Center (ACC), the largest independent oncology group in central Texas. The partnership expands Elligo’s Research Ready network to include its first oncology practice, broadening Elligo’s therapeutic specialization and allowing ACC’s oncologists to offer research as a care option. ACC is currently enrolling patients for studies in breast cancer.
“Partnering with Elligo allows us to bring cutting-edge capabilities to our patients,” said Blayne Rush, MBA, ACC’s CEO. “We’re excited they can remain under our care while benefiting from the innovative treatments available through participation in clinical studies.”
“Bringing the Research Ready network to cancer patients in this area is a milestone achievement in our promise to preserve the trusted patient and physician relationship and unite the best clinical experts with the best research infrastructure,” said John Potthoff, Ph.D., Elligo’s CEO.
Elligo continues to bridge the gap between research and care using its Goes Direct® approach. The company has effectively connected numerous patients and sites to research studies across the industry.
Elligo Health Research accelerates the development of new pharmaceutical, biotechnology, medical device, and diagnostic products. Powered by our novel IntElligo Research Stack™ clinical technology and Goes Direct® approach, we connect the best healthcare experts with the best research technologies and infrastructure, thereby becoming the ultimate healthcare-enabling research organization. While maintaining the integrity of the trusted patient and healthcare physician relationship, we ensure all patients have access to clinical research as a care option by engaging healthcare physicians and their patients who otherwise would not participate in clinical research. We also leverage electronic health records to build local communities of research. Learn more at elligodirect.com.
About Austin Cancer Center
With 11 locations, ACC is a leader in integrated oncology services in the central Texas region. ACC currently offers medical oncology, comprehensive breast care and breast oncology, gynecologic oncology, radiation oncology, neuro oncology and diagnostic and interventional radiology specialties. ACC delivers effective, value-based care and improves physical and mental outcomes for the patients in our community. ACC has key partnerships with multiple hospital systems in central Texas and provides expert care at Austin CyberKnife.